Pages that link to "Q86773095"
Jump to navigation
Jump to search
The following pages link to Comparative evaluation of the efficiency of prostatotropic agents of natural origin in experimental benign prostatic hyperplasia (Q86773095):
Displaying 2 items.
- Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms (Q21256691) (← links)
- Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats (Q40921290) (← links)